Amit Kumar has bought ANIX on 11 days since Oct 2018

Kumar Amit is a Person and serves as Chairman and Chief Executive Officer of Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer( He has also served on the Board of the American Cancer Society since 2016 and sits on boards of other public and private companies(

Dr. Kumar’s background spans biotechnology, venture capital, and executive leadership. He has been an investor, founder, director, and CEO of several technology enterprises, including leading CombiMatrix Corporation as CEO for a decade while it was listed on NASDAQ, and he also worked in venture capital with OAK Investment Partners( His education includes an AB in Chemistry from Occidental College, graduate study at Stanford University and Caltech, a Ph.D. from Caltech, and a post-doctoral fellowship at Harvard(

Written by Perplexity from public sources.